Centrolobol is primarily studied for its biological activity, particularly its anti-inflammatory and cytotoxic properties. It has shown potential in inhibiting the growth of certain cancer cell lines, making it of interest in anticancer research. The compound also exhibits significant activity against parasitic infections, including those caused by trypanosomes, which are responsible for diseases like African sleeping sickness. Due to its ability to modulate immune responses, centrolobol may serve as a lead compound in developing new therapeutic agents for inflammatory diseases. Its natural origin and structural complexity also make it valuable in pharmacological studies aiming to understand structure-activity relationships in bioactive natural products.